NAMPT and Obesity: Increased visfatin was not only observed in hypertension but also reported to increase the risk of obesity-related malignancies such as breast, endometrial, and colorectal cancer in females, whereas oral squamous cell carcinoma and gastric and bladder cancer in males [15].